These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 38477472)

  • 1. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating.
    Tanneti NS; Patel AK; Tan LH; Marques AD; Perera RAPM; Sherrill-Mix S; Kelly BJ; Renner DM; Collman RG; Rodino K; Lee C; Bushman FD; Cohen NA; Weiss SR
    mBio; 2024 Apr; 15(4):e0312923. PubMed ID: 38477472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating.
    Tanneti NS; Patel AK; Tan LH; Marques AD; Perera RAPM; Sherrill-Mix S; Kelly BJ; Renner DM; Collman RG; Rodino K; Lee C; Bushman FD; Cohen NA; Weiss SR
    bioRxiv; 2023 Dec; ():. PubMed ID: 37662273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
    Nchioua R; Schundner A; Kmiec D; Prelli Bozzo C; Zech F; Koepke L; Graf A; Krebs S; Blum H; Frick M; Sparrer KMJ; Kirchhoff F
    J Virol; 2022 Jun; 96(11):e0059422. PubMed ID: 35543509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue.
    Shi G; Li T; Lai KK; Johnson RF; Yewdell JW; Compton AA
    Nat Commun; 2024 Jan; 15(1):889. PubMed ID: 38291024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Omicron Specific Mutations Affecting Infectivity, Fusogenicity, and Partial TMPRSS2-Independency.
    Strobelt R; Broennimann K; Adler J; Shaul Y
    Viruses; 2023 May; 15(5):. PubMed ID: 37243215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity.
    Khatri R; Siddqui G; Sadhu S; Maithil V; Vishwakarma P; Lohiya B; Goswami A; Ahmed S; Awasthi A; Samal S
    Med Microbiol Immunol; 2023 Feb; 212(1):103-122. PubMed ID: 36583790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1.
    Nchioua R; Schundner A; Klute S; Koepke L; Hirschenberger M; Noettger S; Fois G; Zech F; Graf A; Krebs S; Braubach P; Blum H; Stenger S; Kmiec D; Frick M; Kirchhoff F; Sparrer KM
    Life Sci Alliance; 2023 Jun; 6(6):. PubMed ID: 36977594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ancestral Lineage of SARS-CoV-2 Is More Stable in Human Biological Fluids than Alpha, Beta, and Omicron Variants of Concern.
    Kwon T; Gaudreault NN; Meekins DA; McDowell CD; Cool K; Richt JA
    Microbiol Spectr; 2023 Feb; 11(1):e0330122. PubMed ID: 36688691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells.
    Zhu Y; Chew KY; Wu M; Karawita AC; McCallum G; Steele LE; Yamamoto A; Labzin LI; Yarlagadda T; Khromykh AA; Wang X; Sng JDJ; Stocks CJ; Xia Y; Kollmann TR; Martino D; Joensuu M; Meunier FA; Balistreri G; Bielefeldt-Ohmann H; Bowen AC; Kicic A; Sly PD; Spann KM; Short KR
    PLoS Biol; 2022 Aug; 20(8):e3001728. PubMed ID: 35913989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry.
    Sakurai Y; Okada S; Ozeki T; Yoshikawa R; Kinoshita T; Yasuda J
    mSphere; 2024 Sep; 9(9):e0033824. PubMed ID: 39191389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species.
    Essaidi-Laziosi M; Pérez-Rodríguez FJ; Alvarez C; Sattonnet-Roche P; Torriani G; Bekliz M; Adea K; Lenk M; Suliman T; Preiser W; Müller MA; Drosten C; Kaiser L; Eckerle I
    Virus Res; 2024 Jan; 339():199255. PubMed ID: 38389324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant.
    Laine L; Skön M; Väisänen E; Julkunen I; Österlund P
    Front Immunol; 2022; 13():1016108. PubMed ID: 36248817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.
    Banerjee A; Lew J; Kroeker A; Baid K; Aftanas P; Nirmalarajah K; Maguire F; Kozak R; McDonald R; Lang A; Gerdts V; Straus SE; Gilbert L; Li AX; Mozafarihashjin M; Walmsley S; Gingras AC; Wrana JL; Mazzulli T; Colwill K; McGeer AJ; Mubareka S; Falzarano D
    Med; 2022 Jun; 3(6):422-432.e3. PubMed ID: 35437520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.
    Chiu MC; Li C; Liu X; Song W; Wan Z; Yu Y; Huang J; Xiao D; Chu H; Cai JP; To KK; Yuen KY; Zhou J
    mBio; 2022 Aug; 13(4):e0194422. PubMed ID: 35938726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids.
    Flagg M; Goldin K; Pérez-Pérez L; Singh M; Williamson BN; Pruett N; Hoang CD; de Wit E
    Emerg Microbes Infect; 2023 Dec; 12(2):2276338. PubMed ID: 37883246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Omicron Induces Enhanced Mucosal Interferon Response Compared to other Variants of Concern, Associated with Restricted Replication in Human Lung Tissues.
    Alfi O; Hamdan M; Wald O; Yakirevitch A; Wandel O; Oiknine-Djian E; Gvili B; Knoller H; Rozendorn N; Golan Berman H; Adar S; Vorontsov O; Mandelboim M; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells.
    Zhao H; Lu L; Peng Z; Chen LL; Meng X; Zhang C; Ip JD; Chan WM; Chu AW; Chan KH; Jin DY; Chen H; Yuen KY; To KK
    Emerg Microbes Infect; 2022 Dec; 11(1):277-283. PubMed ID: 34951565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages.
    Qing E; Gallagher T
    mBio; 2023 Aug; 14(4):e0017123. PubMed ID: 37382441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs According to Viral Variants.
    Salmona M; Chaix ML; Feghoul L; Mahjoub N; Maylin S; Schnepf N; Jacquier H; Walle EM; Helary M; Mellon G; Osinski N; Zebiche W; Achili Y; Amarsy R; Mahé V; Le Goff J; Delaugerre C
    Microbiol Spectr; 2022 Dec; 10(6):e0213322. PubMed ID: 36346252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.